about
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trialA Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderRating scales measuring the severity of psychotic depressionConsistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depressionTransdiagnostic group CBT vs. standard group CBT for depression, social anxiety disorder and agoraphobia/panic disorder: Study protocol for a pragmatic, multicenter non-inferiority randomized controlled trial.Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validityEffectiveness of adjuvant occupational therapy in employees with depression: design of a randomized controlled trial.A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.Assessing full remission.Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.An item response theory evaluation of three depression assessment instruments in a clinical sampleA randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.Suicidal thoughts and reasons for living in hospitalized patients with severe depression: post-hoc analyses of a double-blind randomized trial of duloxetine.Everyday functional ability across different phases of bipolar disorder.Can a one-item mood scale do the trick? Predicting relapse over 5.5-years in recurrent depression.An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder.Psychometric properties of responses by clinicians and older adults to a 6-item Hebrew version of the Hamilton Depression Rating Scale (HAM-D6).From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient SamplesRating scales in depression: limitations and pitfalls.Rating scales for depression and anxiety: a current perspective.Measuring depression: comparison and integration of three scales in the GENDEP study.Efficacy comparison of duloxetine and SSRIs at doses approved in Japan.Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label studyThe differential influence of life stress on individual symptoms of depressionCharacterizing the therapeutic response to deep brain stimulation for treatment-resistant depression: a single center long-term perspective.Clinical effectiveness of integrating depression care management into medicare home health: the Depression CAREPATH Randomized trial.The Major Depressive Disorder Hierarchy: Rasch Analysis of 6 items of the Hamilton Depression Scale Covering the Continuum of Depressive Syndrome.The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measuresA randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in JapanEstablishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).Attention and memory biases as stable abnormalities among currently depressed and currently remitted individuals with unipolar depressionAssessment of outcome in depression.From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant FindingsEysenck's Two Big Personality Factors and Their Relationship to Depression in Patients with Chronic Idiopathic Pain Disorder: A Clinimetric Validation Analysis.Pharmacogenetic studies in depression: a proposal for methodologic guidelines.No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.Family psychoeducation for major depressive disorder - study protocol for a randomized controlled trialMeasuring psychotic depression.Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account
P2860
Q21245266-C77E9E1E-7A7F-4D46-A636-F4C2EA10BC2AQ24602988-8CABE2F3-C1E2-4CCB-80EA-55431300A857Q28081485-65B9BA70-41FD-44FA-BF3E-9C1CEB81A097Q28550946-F63A9509-0747-47EE-80ED-4AD47201ECE0Q30836139-D7FDEBAA-80B8-4ECC-BD78-B0B595E1C4C0Q30882594-0F2D4095-2568-4823-9276-5ECB99431EAEQ30985190-D62DA4B8-2051-465A-8D0E-E3BF39797D36Q33694937-9EE0C35E-34B5-442C-A77C-B95D6F014743Q33782206-1BB3FB4A-E6FE-47D6-8331-45E75B74EA3DQ33960815-BB177F59-1C46-4D51-9789-BC256D3E8B73Q34132596-F66B701B-29BF-4800-8EF9-8AE79523A005Q34312864-586476CC-3AED-4F08-9C39-4AD5F41A1D85Q34315128-827A755D-6E96-4E38-8628-C795FA2EBE88Q34331858-A9FD2E8D-FCAE-49CE-942C-FEF93CC5E588Q34342857-F6BF4F4B-769E-4007-AF92-DBE5CA99D4C6Q34442114-63DC987E-FC5A-4754-8E39-EA9CD5B4D853Q34464934-EF810AE2-9B89-40BE-9E6A-FE43A417FEEDQ34529669-570B7B27-82CC-4719-A264-0B448D3D66E5Q34546238-15A666F5-9781-4222-A58A-42B8E9150FE8Q34554324-4B672320-ED87-4059-A071-347896A4518DQ34621431-AD4529FA-8959-45A4-9F1D-26DE4DA1E475Q34699544-3242D07E-4801-4ABF-BB26-D215FDF231EAQ34977592-7BBD0F05-C8D5-4B38-A8C2-7347903E2268Q35062660-F85484E1-7CF2-4ECE-A1A8-B4EFCC95DA8AQ35598232-D78FF389-D96B-4496-88F9-068DAF209805Q35739952-3AB23FF9-A28F-4D6E-A228-DAC550661663Q35891999-DA9ED21B-7619-4F06-A7C3-22620B2D17AFQ36257510-69BF9AF5-29B0-4CFE-AE30-50750F650DDCQ36296747-6BA535E6-F8D1-4553-918E-6DDAB27A9E7FQ36341769-0D9FD2FA-8FDE-494F-8FFF-C5ED2CB84EC9Q36387127-695260A4-A691-4FEC-B4C5-48CBDE5A2B4CQ36418546-E60640D1-24EF-4BBB-B582-CF3C596B7A9EQ36511681-6C390D80-06E8-41E6-B31E-BD2E128A3475Q36601436-6DD10DF0-3ECB-4A38-BF07-5C1290BA2FAAQ36857874-839D21D8-961B-4904-90AA-8D03B3E7D16CQ36904466-F918C53C-470A-400D-857F-A20BC5C7781DQ37116846-98430C3C-5AB2-4E4C-87E6-5B640A6655ABQ37221218-BC64D1E1-6DB4-4862-9495-58088CCCB440Q37284824-629B4035-89FC-465B-BE10-C4F21AAEFB36Q37695087-2E269115-A2ED-4A72-9633-F3E52D553A3D
P2860
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Quantitative rating of depressive states.
@en
type
label
Quantitative rating of depressive states.
@en
prefLabel
Quantitative rating of depressive states.
@en
P2093
P1476
Quantitative rating of depressive states.
@en
P2093
P304
P356
10.1111/J.1600-0447.1975.TB00002.X
P407
P577
1975-03-01T00:00:00Z